Editas Medicine (EDIT) Non Operating Income (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Non Operating Income data on file, last reported at -$569000.0 in Q3 2025.

• On a quarterly basis, Non Operating Income fell 116.14% year-over-year to -$569000.0 in Q3 2025; TTM through Sep 2025 was -$987000.0, a 105.5% decrease from a year earlier, with the FY2024 full-year figure at $14.1 million, down 11.92% from the prior year.
• Non Operating Income for Q3 2025 stood at -$569000.0, up from -$1.7 million in the prior quarter.
• Over the last five years, Non Operating Income for EDIT reached as high as $5.1 million in Q3 2023 and fell as low as -$1.7 million in Q2 2025.
• Historically, Non Operating Income has averaged $1.8 million across 5 years, with a median of $1.2 million in 2024.
• Across the five-year window, Non Operating Income surged 1456.32% in 2022 and sank 139.36% in 2025, its largest moves.
• Year by year, Non Operating Income stood at $174000.0 in 2021, then jumped by 1456.32% to $2.7 million in 2022, then surged by 87.89% to $5.1 million in 2023, then plunged by 76.45% to $1.2 million in 2024, then sank by 147.5% to -$569000.0 in 2025.
• Per Business Quant data, the three most recent Non Operating Income figures were -$569000.0 in Q3 2025, -$1.7 million in Q2 2025, and $75000.0 in Q1 2025.